Allogeneic hematopoietic stem cell transplantation in a patient affected by large granular lymphocyte leukemia and multiple sclerosis

Ann Hematol. 2004 Jun;83(6):403-5. doi: 10.1007/s00277-003-0801-3. Epub 2003 Nov 26.

Abstract

We describe a 57-year-old man, affected by large granular lymphocyte (LGL) leukemia and concomitant primary progressive multiple sclerosis (MS), treated with allogeneic hematopoietic stem cell transplantation (HSCT) from an HLA-identical sibling. The patient was conditioned with fludarabine, busulphan, and cyclophosphamide. Graft-versus-host disease (GVHD) prophylaxis consisted of cyclosporine and short-term methotrexate. At 3 years follow-up, the patient is in complete remission of LGL with a marked improvement in neurological conditions. This is the first case of allogeneic HSCT in a patient with LGL leukemia and concomitant primary progressive MS. Allogeneic HSCT, performed in our patient to cure the lymphoproliferative disorder, improved the clinical course of MS.

Publication types

  • Case Reports

MeSH terms

  • Follow-Up Studies
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Leukemia, T-Cell / complications
  • Leukemia, T-Cell / pathology
  • Leukemia, T-Cell / therapy*
  • Male
  • Middle Aged
  • Multiple Sclerosis / complications
  • Multiple Sclerosis / pathology
  • Multiple Sclerosis / therapy*
  • Transplantation Conditioning / methods
  • Transplantation, Homologous
  • Treatment Outcome